Countries China
FDA Approves iRegene's NouvNeu001, Marking Milestone in Parkinson's Disease Treatment
U.S. Food and Drug Administration (FDA) approved the IND application for NouvNeu001, a cell therapy product from iRegene therapeutics targeting Parkinson's...
June 25, 2024 | News
EU Approves HUTCHMED's FRUZAQLA® for Previously Treated Metastatic Colorectal Cancer
— Approval for previously treated metastatic colorectal cancer based on results from positive, global, Phase III FRESCO-2 Trial — — FRUZ...
June 24, 2024 | News
Dizal's Golidocitinib Approved in China as First JAK1-Only Inhibitor for Relapsed or Refractory Peripheral T-Cell Lymphoma
Golidocitinib is a first-in-class Janus kinase 1 (JAK1) only inhibitor approved for the treatment of r/r PTCL based on results from the multinational piv...
June 20, 2024 | News
YolTech Partners with KACTUS to Commercialize Breakthrough DNA Editor YolCas12TM in Greater China
YolTech, a clinical-stage biopharmaceutical company specializing in mRNA-LNP delivery for in vivo gene editing therapies, has partnered with KACT...
June 19, 2024 | News
ReviR Therapeutics and Asieris Pharmaceuticals Achieve Milestone in Cancer Treatment Collaboration
ReviR Therapeutics, a biotechnology company specializing in the development of small molecule RNA splicing modulators for neurogenetic diseases and oncolog...
June 18, 2024 | News
FDA Clears Zymeworks' ZW171 for Mesothelin-Expressing Cancers
“We are excited to reach this R&D milestone with ZW171, reflecting our commitment to advancing innovative therapies for cancer treatment,...
June 18, 2024 | News
Venus Medtech Achieves Milestone with First U.S. Implantation of VenusP-Valve in PROTEUS Study
Venus Medtech, a leading provider of integrated solutions for transcatheter structural heart valvular therapies in China, announced today th...
June 17, 2024 | News
Ascentage Pharma Secures $1.3 Billion Deal with Takeda for Global Rights to Olverembatinib
Ascentage Pharma has executed an Exclusive Option to License Global Rights to Olverembatinib worldwide other than China and a few other areas. ...
June 17, 2024 | News
Ethypharm Expands Portfolio with Acquisition of Mesalazine Suppository by Chinese Affiliate
Ethypharm is pleased to announce the acquisition of a suppository form of Mesalazine by its Chinese affiliate, Shanghai Ethypharm Pharmaceuticals Ltd, from...
June 14, 2024 | News
Zymeworks Secures $8 Million Milestone Payment and Advances Cancer Treatment with FDA and NMPA Approvals
Pursuant to the terms of the licensing agreement between Zymeworks and BeiGene, Zymeworks is entitled to receive an $8 million milestone payment from Bei...
June 11, 2024 | News
Xiao-I Corporation Secures Major Contract with Multinational Health Tech Conglomerate to Revolutionize Knowledge Management
Xiao-I Corporation , a leading AI company, announces a contract is secured from a renowned multinational conglomerate in the health technology sector base ...
June 07, 2024 | News
Shanghai MicuRx Achieves Key Milestone in Combatting Drug-Resistant Infections with Successful Phase I Trial of MRX-8
According to the World Health Organization (WHO), millions of patients face treatment difficulties or even life-threatening conditions due to resistant b...
June 07, 2024 | News
OBiO Technology Launches Clinical Evaluation and Translation Center for Pediatric Rare Diseases
OBiO Technology, a world leading contract development and manufacturing organization for cell and gene therapy, officially launched the "Center f...
May 31, 2024 | News
Kexing Biopharm’s Subsidiary Receives Approval for Clinical Trials of Innovative GB08 Growth Hormone
Kexing Biopharm announced that Shenzhen Kexing Pharmaceutical Co., Ltd., its wholly-owned subsidiary, recently received a Notice of Approval for Drug Clini...
May 31, 2024 | News
Most Read
- Bridging the Vision Gap: Roche’s Ahmed Elhusseiny on Eye Health Priorities in Asia Pacific
- How Merck’s India-Based Navi Mumbai Centre is Reimagining Formulation Science for the Global Generics Market
- Advancing Cell & Gene Therapy in APJ: How Thermo Fisher Enables Breakthrough Innovation
- AstraZeneca’s Vision for Chronic Kidney Disease: Sylvia Varela on Transforming CKD Care in Asia
- ACG Leads the Charge in Vegan Capsules: Innovation, Certification, and the Future of Sustainable Pharma
- ORA’s Hybrid Model Reshapes Obesity Care: Dr. Ben Ng on Bridging Telehealth and In-Person Treatment
- Heather Hargett on How Merck’s HUB Organoids Acquisition is Reshaping 3D Cell Culture and Drug Development
- Health2Sync's Vision for Diabetes Care: Transforming Outcomes Through Technology and Partnerships
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
Editor Picks
